PACS/RIS developer PaxeraHealth announced a 55% increase in total revenue for its fiscal 2019 in a preliminary report.
The growth reflects the company's shift toward higher value projects, particularly in the U.S. and Latin America, PaxeraHealth said. The company won 172 new projects in the second half of 2019 and doubled the size of its sales and support teams in certain markets.
